Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma.
Cancer Cell
| Authors | |
| Keywords | |
| Abstract | In this issue of Cancer Cell, Bosse et al. report GPC2 as a therapeutic target in neuroblastoma. They show that GPC2 is selectively expressed on the cell surface of neuroblastoma and is a dependency in this disease. Moreover, they demonstrate the therapeutic potential of an antibody-drug conjugate targeting GPC2. |
| Year of Publication | 2017
|
| Journal | Cancer Cell
|
| Volume | 32
|
| Issue | 3
|
| Pages | 271-273
|
| Date Published | 2017 09 11
|
| ISSN | 1878-3686
|
| DOI | 10.1016/j.ccell.2017.08.011
|
| PubMed ID | 28898689
|
| Links | |
| Grant list | R01 NS088355 / NS / NINDS NIH HHS / United States
R35 CA210030 / CA / NCI NIH HHS / United States
|